Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Misses Expectations By $0.84 EPS - Stock Observer
Vir Biotechnology Q1 Earnings Call Highlights
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells $221,100.00 in Stock - Stock Observer
Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political
How Insider Sale and VIR-5500 Milestone at Vir Biotechnology (VIR) Have Changed Its Investment Story
Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares
Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday - Zolmax
Vir Biotechnology (VIR) Expected to Announce Quarterly Earnings on Wednesday
Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth
10 Best Small-Cap Biotech Stocks According to Hedge Funds
Vir Biotechnology (VIR) Is Up 19.1% After Astellas Cancer Pact Closes With $315M Inflows
Can Vir Biotechnology (VIR)'s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?
Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - Stock Observer
Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?
Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | Morningstar
Phase 1 trial designed to assess the safety, pharmacokinetic
Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) PT at $20.44
Should Vir's CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy
Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares
VirBiotechnology News
How to trade CFDs in Australia: Gold CFDs, Crypto CFDs, Forex CFDs and More
How to trade popular AI stocks from South Africa: AMD, Intel (INTC) stock, Microsoft
Forex Market Analysis: What Factors Are Influencing the GBP/AED Exchange Rate in 2026?
Commodity market today: UAE to exit OPEC on May 1, how will this impact global oil prices?
Solana (SOL/USD) Price Prediction: How Is Solana (SOL) Performing in the UAE Market Right Now?
Bitcoin (BTC/USD) Trends in South Africa 2026: What Is Driving Bitcoin Adoption in South Africa in 2026?
Why Oil Keeps Rising: Strait of Hormuz Crisis, Middle East Conflict, OPEC+ Strategy and More
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?
Latest news
Show more
Crypto Market News Today: Dogecoin DOGEUSD Surges Past $0.115 as Meme Coin Momentum Builds in 2026
Gold Price Today, May 07: XAU/USD Soars 2.73% to Record $4,685 Amid Market Rally
Forex Market Today: USD/JPY Surges Above 150 as Dollar Strength Returns Amid Fed Rate Outlook
Q1 2026 Earnings to Watch Today: Coca-Cola (KO) Set to Report Before Market Open
Gold Price Today, May 06: XAU/USD Hits Fresh Highs Above $4,600 as Safe-Haven Demand Surges Amid Global Uncertainty
Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel
